|Genomic hallmarks of localized, non-indolent prostate cancer|
M Fraser, VY Sabelnykova, TN Yamaguchi, LE Heisler, J Livingstone, ...
Nature 541 (7637), 359-364, 2017
|Widespread and functional RNA circularization in localized prostate cancer|
S Chen, V Huang, X Xu, J Livingstone, F Soares, J Jeon, Y Zeng, JT Hua, ...
Cell 176 (4), 831-843. e22, 2019
|Risk SNP-mediated promoter-enhancer switching drives prostate cancer through lncRNA PCAT19|
JT Hua, M Ahmed, H Guo, Y Zhang, S Chen, F Soares, J Lu, S Zhou, ...
Cell 174 (3), 564-575. e18, 2018
|Onco-multi-OMICS approach: a new frontier in cancer research|
S Chakraborty, MI Hosen, M Ahmed, HU Shekhar
BioMed research international 2018, 2018
|Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer|
H Guo, M Ahmed, F Zhang, CQ Yao, SD Li, Y Liang, J Hua, F Soares, ...
Nature genetics 48 (10), 1142-1150, 2016
|ONECUT2 is a driver of neuroendocrine prostate cancer|
H Guo, X Ci, M Ahmed, JT Hua, F Soares, D Lin, L Puca, A Vosoughi, ...
Nature communications 10 (1), 278, 2019
|Lysine-specific demethylase 1 has dual functions as a major regulator of androgen receptor transcriptional activity|
C Cai, HH He, S Gao, S Chen, Z Yu, Y Gao, S Chen, MW Chen, J Zhang, ...
Cell reports 9 (5), 1618-1627, 2014
|Reactivation of androgen receptor-regulated lipid biosynthesis drives the progression of castration-resistant prostate cancer|
W Han, S Gao, D Barrett, M Ahmed, D Han, JA Macoska, HH He, C Cai
Oncogene 37 (6), 710-721, 2018
|LSD1-Mediated Epigenetic Reprogramming Drives CENPE Expression and Prostate Cancer ProgressionCENPE Is a Therapeutic Target for CRPC|
Y Liang, M Ahmed, H Guo, F Soares, JT Hua, S Gao, C Lu, C Poon, ...
Cancer research 77 (20), 5479-5490, 2017
|Transposable elements are a significant contributor to tandem repeats in the human genome|
M Ahmed, P Liang
Comparative and Functional Genomics 2012, 2012
|A computational approach for identification of epitopes in dengue virus envelope protein: a step towards designing a universal dengue vaccine targeting endemic regions|
S Chakraborty, R Chakravorty, M Ahmed, A Rahman, TM Waise, ...
In silico biology 10 (5-6), 235-246, 2010
|Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer|
S Gao, S Chen, D Han, Z Wang, M Li, W Han, A Besschetnova, M Liu, ...
Nature genetics 52 (10), 1011-1017, 2020
|Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer|
S Zhou, JR Hawley, F Soares, G Grillo, M Teng, SA Madani Tonekaboni, ...
Nature communications 11 (1), 441, 2020
|Comparative network clustering of direct repeats (DRs) and cas genes confirms the possibility of the horizontal transfer of CRISPR locus among bacteria|
S Chakraborty, AP Snijders, R Chakravorty, M Ahmed, AM Tarek, ...
Molecular Phylogenetics and Evolution 56 (3), 878-887, 2010
|Genome-wide germline correlates of the epigenetic landscape of prostate cancer|
KE Houlahan, YJ Shiah, A Gusev, J Yuan, M Ahmed, A Shetty, ...
Nature medicine 25 (10), 1615-1626, 2019
|An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer|
A Davies, S Nouruzi, D Ganguli, T Namekawa, D Thaper, S Linder, ...
Nature cell biology 23 (9), 1023-1034, 2021
|Cistrome partitioning reveals convergence of somatic mutations and risk variants on master transcription regulators in primary prostate tumors|
P Mazrooei, KJ Kron, Y Zhu, S Zhou, G Grillo, T Mehdi, M Ahmed, ...
Cancer Cell 36 (6), 674-689. e6, 2019
|Integration of online omics-data resources for cancer research|
T Das, G Andrieux, M Ahmed, S Chakraborty
Frontiers in Genetics 11, 578345, 2020
|Circulating miRNAs as non-invasive biomarkers to predict aggressive prostate cancer after radical prostatectomy|
C Hoey, M Ahmed, A Fotouhi Ghiam, D Vesprini, X Huang, K Commisso, ...
Journal of translational medicine 17 (1), 1-11, 2019
|Forkhead domain mutations in FOXA1 drive prostate cancer progression|
S Gao, S Chen, D Han, D Barrett, W Han, M Ahmed, S Patalano, ...
Cell research 29 (9), 770-772, 2019